Gts Securities »

Adaptive Biotechnologies Cor shares owned by Gts Securities

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 15k 4.90

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
Vanguard Group
ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Point72 Asset Management
Massachusetts Financial Services
Dimensional Fund Advisors
Blue Water Life Science Advisors
Braidwell
Gilder, Gagnon, Howe & Co
Eagle Health Investments
Federated Investors
Standard Life Aberdeen
Nordea Investment Management Ab

View all funds holding Adaptive Biotechnologies Cor